The Wall Street analyst predicted that AGENUS’s share price could reach $14.00 by Mar 2, 2023. The average AGENUS stock price prediction forecasts a potential upside of 498.29% from the current AGEN share price of $2.34.
Correspondingly, Why did AGEN drop today? Shares of Agenus ( AGEN -3.49% ) dropped more than 32% this morning after the company gave investors bad news regarding its experimental cancer immunotherapy balstilimab. The company has withdrawn the Biologics License Application (BLA) that the Food and Drug Administration (FDA) began reviewing earlier this year.
Is AGEN stock a buy? Agenus has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Furthermore, Why is agenus stock going up?
Why Agenus Stock Is Crushing It Today
In response to the impressive clinical progress of Agenus’ anti-cancer checkpoint inhibitor platform, Wainwright raised its 12-month price target on the biotech’s shares to $14 ahead of the opening bell this morning.
What kind of company is AGEN?
Agenus is an immuno-oncology company focused on the discovery and development of revolutionary new treatments that engage the body’s immune system to benefit patients suffering from cancer.
Where can I buy agenus stock? Agenus Inc. (Agenus) is an immuno-oncology (I-O) company. Stash allows you to purchase smaller pieces of investments, called fractional shares, rather than having to pay the full price for a whole share. , you can buy Agenus Inc. stock in any dollar amount, or any other fund or stock you know on Stash.
When did Agen go public? The company has pioneered immunotherapies, including heat shock protein-based cancer vaccines, a program that has developed into its Prophage Series of personalized anti-cancer vaccines. Antigenics became a public company in February 2000 on the NASDAQ exchange with the ticker symbol AGEN.
How many employees does agenus? Compare AGEN With Other Stocks
| Agenus Annual Number of Employees | |
|---|---|
| 2020 | 359 |
| 2019 | 328 |
| 2018 | 294 |
| 2017 | 255 |
When did agenus go public?
The company has pioneered immunotherapies, including heat shock protein-based cancer vaccines, a program that has developed into its Prophage Series of personalized anti-cancer vaccines. Antigenics became a public company in February 2000 on the NASDAQ exchange with the ticker symbol AGEN.
Does agenus stock pay dividends? AGENUS (NASDAQ: AGEN) does not pay a dividend.
What is AGEN1181?
AGEN1181 is a multipurpose, second-generation “Fc-engineered” anti-CTLA-4 antibody with enhanced tumor fighting abilities, designed to generate responses in a larger number of patients and improve immunogenicity.
